CSL Shares Bounce Over $100 as Investors Watch for Bottom After Downgrade
CSL shares closed at A$102.95 in Sydney, up 3.5% from Tuesday, as investors moved into defensive healthcare stocks. The company issued no new operating update, with its last ASX filing on June 9 covering lapsed rights. CSL remains down 42.67% for 2026 after May’s profit warning. The S&P/ASX 200 rose 0.57% Wednesday, with healthcare up 0.88%.